These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16567169)

  • 21. Proteomic profiling of cholangiocarcinoma: diagnostic potential of SELDI-TOF MS in malignant bile duct stricture.
    Scarlett CJ; Saxby AJ; Nielsen A; Bell C; Samra JS; Hugh T; Baxter RC; Smith RC
    Hepatology; 2006 Sep; 44(3):658-66. PubMed ID: 16941699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteomic analysis to identify biomarker proteins in pancreatic ductal adenocarcinoma.
    Chung JC; Oh MJ; Choi SH; Bae CD
    ANZ J Surg; 2008 Apr; 78(4):245-51. PubMed ID: 18366394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for proteomic analysis of seminal plasma in patients with delayed semen liquefaction].
    Sun L; Bai J; Chen SL; Qiu ZL; Zhang WQ; Yang J; Xing FQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Apr; 27(4):442-4. PubMed ID: 17545025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteomic analysis of neuroblastoma microenvironment: effect of the host-tumor interaction on disease progression.
    Turner KE; Kumar HR; Hoelz DJ; Zhong X; Rescorla FJ; Hickey RJ; Malkas LH; Sandoval JA
    J Surg Res; 2009 Sep; 156(1):116-22. PubMed ID: 19592021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel peptides secreted from human neuroblastoma: useful clinical tools?
    Sandoval JA; Hoelz DJ; Woodruff HA; Powell RL; Jay CL; Grosfeld JL; Hickeyd RJ; Malkas LH
    J Pediatr Surg; 2006 Jan; 41(1):245-51. PubMed ID: 16410142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteomic classification of pancreatic adenocarcinoma tissue using protein chip technology.
    Scarlett CJ; Smith RC; Saxby A; Nielsen A; Samra JS; Wilson SR; Baxter RC
    Gastroenterology; 2006 May; 130(6):1670-8. PubMed ID: 16697731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical proteomics: searching for better tumour markers with SELDI-TOF mass spectrometry.
    Engwegen JY; Gast MC; Schellens JH; Beijnen JH
    Trends Pharmacol Sci; 2006 May; 27(5):251-9. PubMed ID: 16600386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Serum diagnosis of head and neck squamous cell carcinoma using surface-enhanced desorption ionization mass spectrometry and artificial neural network analyses].
    Cao SM; Guo X; Chen FJ; Yang AK; Chen WK; Li NW
    Ai Zheng; 2007 Jul; 26(7):767-70. PubMed ID: 17626756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Profiling of nuclear extract proteins from human neuroblastoma cell lines: the search for fingerprints.
    Escobar MA; Hoelz DJ; Sandoval JA; Hickey RJ; Grosfeld JL; Malkas LH
    J Pediatr Surg; 2005 Feb; 40(2):349-58. PubMed ID: 15750928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer.
    Fiedler GM; Leichtle AB; Kase J; Baumann S; Ceglarek U; Felix K; Conrad T; Witzigmann H; Weimann A; Schütte C; Hauss J; Büchler M; Thiery J
    Clin Cancer Res; 2009 Jun; 15(11):3812-9. PubMed ID: 19470732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of GRP75 as an independent favorable prognostic marker of neuroblastoma by a proteomics analysis.
    Hsu WM; Lee H; Juan HF; Shih YY; Wang BJ; Pan CY; Jeng YM; Chang HH; Lu MY; Lin KH; Lai HS; Chen WJ; Tsay YG; Liao YF; Hsieh FJ
    Clin Cancer Res; 2008 Oct; 14(19):6237-45. PubMed ID: 18829503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An extended Markov blanket approach to proteomic biomarker detection from high-resolution mass spectrometry data.
    Oh JH; Gurnani P; Schorge J; Rosenblatt KP; Gao JX
    IEEE Trans Inf Technol Biomed; 2009 Mar; 13(2):195-206. PubMed ID: 19126475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reproducibility of serum protein profiling by systematic assessment using solid-phase extraction and matrix-assisted laser desorption/ionization mass spectrometry.
    Callesen AK; Christensen Rd; Madsen JS; Vach W; Zapico E; Cold S; Jørgensen PE; Mogensen O; Kruse TA; Jensen ON
    Rapid Commun Mass Spectrom; 2008; 22(3):291-300. PubMed ID: 18181248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Tree analysis pattern of mass spectral urine profiles in differential diagnosis of bladder transitional cell carcinoma].
    Wu DL; Zhang YF; Guan M; Liu WW; Xu YM; Jin SB; Zhang J; Jin CR; Lü Y
    Zhonghua Zhong Liu Za Zhi; 2007 Apr; 29(4):274-7. PubMed ID: 17760254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry on identifing biomarkers of endometriosis.
    Zhang H; Feng J; Chang XH; Li ZX; Wu XY; Cui H
    Chin Med J (Engl); 2009 Feb; 122(4):373-6. PubMed ID: 19302738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Use of laser capture microdissection and surface-enhanced laser desorption ionization time-of-flight mass spectrometry to screen differential proteins in lung adenocarcinoma and lung squamous carcinoma].
    Tian YX; Yang SY; Nan YD; Zhang W; Zhou B; Bu LN; Huo SF; Yu JK; Zheng S
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(3):145-8. PubMed ID: 18361807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discrimination analysis of mass spectrometry proteomics for ovarian cancer detection.
    Hong YJ; Wang XD; Shen D; Zeng S
    Acta Pharmacol Sin; 2008 Oct; 29(10):1240-6. PubMed ID: 18817630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined experimental and statistical strategy for mass spectrometry based serum protein profiling for diagnosis of breast cancer: a case-control study.
    Callesen AK; Vach W; Jørgensen PE; Cold S; Tan Q; Depont Christensen R; Mogensen O; Kruse TA; Jensen ON; Madsen JS
    J Proteome Res; 2008 Apr; 7(4):1419-26. PubMed ID: 18303830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis of early relapse in ovarian cancer using serum proteomic profiling.
    Oh JH; Gao J; Nandi A; Gurnani P; Knowles L; Schorge J
    Genome Inform; 2005; 16(2):195-204. PubMed ID: 16901102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tree analysis of mass spectral urine profiles discriminates transitional cell carcinoma of the bladder from noncancer patient.
    Zhang YF; Wu DL; Guan M; Liu WW; Wu Z; Chen YM; Zhang WZ; Lu Y
    Clin Biochem; 2004 Sep; 37(9):772-9. PubMed ID: 15329315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.